MedPath

Instituto Mexicano del Seguro Social

Instituto Mexicano del Seguro Social logo
🇲🇽Mexico
Ownership
Private
Established
1943-01-01
Employees
10K
Market Cap
-
Website
http://www.imss.gob.mx

Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma

Completed
Conditions
Multiple Myeloma
Interventions
First Posted Date
2010-11-04
Last Posted Date
2010-11-04
Lead Sponsor
Instituto Mexicano del Seguro Social
Target Recruit Count
320
Registration Number
NCT01234129
Locations
🇲🇽

Tertiary reference oncology center, Mexico, Distrito Federal, Mexico

Radiotherapy in Primary Mediastinal Lymphoma

Completed
Conditions
Adjuvant Radiotherapy on Complete Remission Patients
Interventions
Radiation: no drugs
First Posted Date
2010-10-28
Last Posted Date
2010-10-28
Lead Sponsor
Instituto Mexicano del Seguro Social
Target Recruit Count
198
Registration Number
NCT01230008
Locations
🇲🇽

Oncology Research Unit, Mèxico DF, DF, Mexico

Effect of Dexamethasone in Postoperative Symptoms After Mastectomy for Breast Cancer

Phase 3
Completed
Conditions
Postoperative Pain
Postoperative Nausea
Postoperative Vomiting
Interventions
Drug: Homologated placebo.
First Posted Date
2010-05-05
Last Posted Date
2010-05-05
Lead Sponsor
Instituto Mexicano del Seguro Social
Target Recruit Count
70
Registration Number
NCT01116713
Locations
🇲🇽

Research Unit in Clinical Epidemiology, Specialties Hospital. Mexican Institute of Sociaql Security, Guadalajara, Jalisco, Mexico

🇲🇽

Breast Clinic. Oncologic Institute of Jalisco, Guadalajara, Jalisco, Mexico

Dexamethasone Improves Postoperative Symptoms After Laparoscopic Cholecystectomy

Phase 3
Completed
Conditions
Postoperative Nausea and Vomiting
Postoperative Pain
Postoperative Fatigue
Interventions
Drug: placebo
First Posted Date
2009-12-11
Last Posted Date
2009-12-11
Lead Sponsor
Instituto Mexicano del Seguro Social
Target Recruit Count
210
Registration Number
NCT01030614
Locations
🇲🇽

Department of Surgery and Department od Anesthesiology. Specialties Hospital. Westerm Medical Center, Mexican Institute of Social Security., Guadalajara, Jalisco, Mexico

Magnesium and Metabolic Syndrome

Phase 4
Completed
Conditions
High Blood Pressure
Hypomagnesemia
Diabetes Mellitus
Interventions
Dietary Supplement: Magnesium chloride
Other: Placebo
First Posted Date
2008-01-29
Last Posted Date
2008-01-29
Lead Sponsor
Instituto Mexicano del Seguro Social
Target Recruit Count
85
Registration Number
NCT00603499
Locations
🇲🇽

Biomedical Research Unit, Durango, Mexico

© Copyright 2025. All Rights Reserved by MedPath